• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

线粒体 DNA 疾病——分子见解与潜在治疗途径。

Mitochondrial DNA disease-molecular insights and potential routes to a cure.

机构信息

Newcastle University Centre for Brain Ageing and Vitality and Wellcome Trust Centre for Mitochondrial Research, Institute for Ageing and Health, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK.

Newcastle University Centre for Brain Ageing and Vitality and Wellcome Trust Centre for Mitochondrial Research, Institute for Ageing and Health, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK.

出版信息

Exp Cell Res. 2014 Jul 1;325(1):38-43. doi: 10.1016/j.yexcr.2014.03.012. Epub 2014 Mar 24.

DOI:10.1016/j.yexcr.2014.03.012
PMID:24675282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4058519/
Abstract

Mitochondrial DNA diseases are common neurological conditions caused by mutations in the mitochondrial genome or nuclear genes responsible for its maintenance. Current treatments for these disorders are focussed on the management of the symptoms, rather than the correction of biochemical defects caused by the mutation. This review focuses on the molecular effects of mutations, the symptoms they cause and current work focusing on the development of targeted treatments for mitochondrial DNA disease.

摘要

线粒体 DNA 疾病是由线粒体基因组或负责其维持的核基因突变引起的常见神经疾病。目前这些疾病的治疗方法主要集中在症状的管理上,而不是纠正突变引起的生化缺陷。这篇综述主要关注突变的分子效应、它们引起的症状以及目前针对线粒体 DNA 疾病的靶向治疗方法的开发工作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2b3/4058519/e084d1b66187/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2b3/4058519/c9f6971d00c4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2b3/4058519/e084d1b66187/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2b3/4058519/c9f6971d00c4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2b3/4058519/e084d1b66187/gr2.jpg

相似文献

1
Mitochondrial DNA disease-molecular insights and potential routes to a cure.线粒体 DNA 疾病——分子见解与潜在治疗途径。
Exp Cell Res. 2014 Jul 1;325(1):38-43. doi: 10.1016/j.yexcr.2014.03.012. Epub 2014 Mar 24.
2
A magic bullet to specifically eliminate mutated mitochondrial genomes from patients' cells.一种专门从患者细胞中消除突变线粒体基因组的神奇疗法。
EMBO Mol Med. 2014 Apr;6(4):434-5. doi: 10.1002/emmm.201303769. Epub 2014 Mar 12.
3
Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations.线粒体靶向锌指核酸酶用于选择性降解携带大规模缺失或点突变的致病性线粒体基因组。
EMBO Mol Med. 2014 Apr;6(4):458-66. doi: 10.1002/emmm.201303672. Epub 2014 Feb 24.
4
Mitochondrial DNA triplication and punctual mutations in patients with mitochondrial neuromuscular disorders.线粒体神经肌肉疾病患者的线粒体DNA复制及点突变
Biochem Biophys Res Commun. 2016 Apr 29;473(2):578-85. doi: 10.1016/j.bbrc.2016.03.126. Epub 2016 Mar 28.
5
Variability of Clinical Phenotypes Caused by Isolated Defects of Mitochondrial ATP Synthase.孤立性线粒体 ATP 合酶缺陷导致的临床表型变异性。
Physiol Res. 2024 Aug 31;73(Suppl 1):S243-S278. doi: 10.33549/physiolres.935407. Epub 2024 Jul 17.
6
Mitochondrial Diseases: Hope for the Future.线粒体疾病:未来的希望。
Cell. 2020 Apr 2;181(1):168-188. doi: 10.1016/j.cell.2020.02.051. Epub 2020 Mar 26.
7
Mitochondrial diseases and ATPase defects of nuclear origin.线粒体疾病与核源性ATP酶缺陷
Biochim Biophys Acta. 2004 Jul 23;1658(1-2):115-21. doi: 10.1016/j.bbabio.2004.04.012.
8
Allotopic Expression of ATP6 in Mouse as a Transgenic Model of Mitochondrial Disease.在小鼠中异位表达 ATP6 作为一种线粒体疾病的转基因模型。
Methods Mol Biol. 2021;2277:1-13. doi: 10.1007/978-1-0716-1270-5_1.
9
Deregulated Mitochondrial DNA in Diseases.疾病中失调的线粒体 DNA。
DNA Cell Biol. 2020 Aug;39(8):1385-1400. doi: 10.1089/dna.2019.5220. Epub 2020 Jan 16.
10
Therapeutic potential of engineering the mitochondrial genome.线粒体基因组工程的治疗潜力。
Biochim Biophys Acta Mol Basis Dis. 2023 Oct;1869(7):166804. doi: 10.1016/j.bbadis.2023.166804. Epub 2023 Jul 8.

引用本文的文献

1
DNA sequence and lesion-dependent mitochondrial transcription factor A (TFAM)-DNA-binding modulates DNA repair activities and products.DNA序列和损伤依赖性线粒体转录因子A(TFAM)-DNA结合调节DNA修复活性和产物。
Nucleic Acids Res. 2024 Dec 11;52(22):14093-14111. doi: 10.1093/nar/gkae1144.
2
Unleashing the potential of CRISPR multiplexing: Harnessing Cas12 and Cas13 for precise gene modulation in eye diseases.释放 CRISPR 多重编辑的潜力:利用 Cas12 和 Cas13 精确调控眼部疾病相关基因。
Vision Res. 2023 Dec;213:108317. doi: 10.1016/j.visres.2023.108317. Epub 2023 Sep 16.
3
Neurodegeneration, Mitochondria, and Antibiotics.

本文引用的文献

1
Disease progression in patients with single, large-scale mitochondrial DNA deletions.单一大规模线粒体 DNA 缺失患者的疾病进展。
Brain. 2014 Feb;137(Pt 2):323-34. doi: 10.1093/brain/awt321. Epub 2013 Nov 25.
2
Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs.通过 mitoTALENs 特异性剔除患者来源细胞中的突变线粒体基因组。
Nat Med. 2013 Sep;19(9):1111-3. doi: 10.1038/nm.3261. Epub 2013 Aug 4.
3
The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A>G mutation--implications for diagnosis and management.
神经退行性变、线粒体与抗生素
Metabolites. 2023 Mar 12;13(3):416. doi: 10.3390/metabo13030416.
4
Detection of UV-Induced Deletions in Mitochondrial DNA.线粒体DNA中紫外线诱导缺失的检测
Methods Mol Biol. 2023;2615:281-292. doi: 10.1007/978-1-0716-2922-2_20.
5
Mitochondrial Cardiomyopathy: The Roles of mt-tRNA Mutations.线粒体心肌病:线粒体转运RNA突变的作用
J Clin Med. 2022 Oct 30;11(21):6431. doi: 10.3390/jcm11216431.
6
Direct evidence of CRISPR-Cas9-mediated mitochondrial genome editing.CRISPR-Cas9介导的线粒体基因组编辑的直接证据。
Innovation (Camb). 2022 Sep 27;3(6):100329. doi: 10.1016/j.xinn.2022.100329. eCollection 2022 Nov 8.
7
The role of mtDNA in oocyte quality and embryo development.线粒体 DNA 在卵母细胞质量和胚胎发育中的作用。
Mol Reprod Dev. 2023 Jul;90(7):621-633. doi: 10.1002/mrd.23640. Epub 2022 Aug 20.
8
Exposure to a Pathological Condition May Be Required for the Cells to Secrete Exosomes Containing mtDNA Aberration.细胞可能需要暴露于病理状态才能分泌含有线粒体DNA畸变的外泌体。
J Nucleic Acids. 2022 Mar 17;2022:7960198. doi: 10.1155/2022/7960198. eCollection 2022.
9
Neurodegenerative and functional signatures of the cerebellar cortex in m.3243A > G patients.患有m.3243A > G突变的患者小脑皮质的神经退行性变和功能特征
Brain Commun. 2022 Feb 3;4(1):fcac024. doi: 10.1093/braincomms/fcac024. eCollection 2022.
10
Genetic Alterations in Mitochondrial DNA Are Complementary to Nuclear DNA Mutations in Pheochromocytomas.嗜铬细胞瘤中线粒体DNA的基因改变与核DNA突变互补。
Cancers (Basel). 2022 Jan 6;14(2):269. doi: 10.3390/cancers14020269.
英国医学研究理事会(MRC)线粒体疾病患者队列研究:m.3243A>G 突变相关的临床表型——对诊断和管理的影响。
J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):936-8. doi: 10.1136/jnnp-2012-303528. Epub 2013 Jan 25.
4
Genetic engineering of human pluripotent cells using TALE nucleases.利用 TALE 核酸酶对人类多能细胞进行基因工程改造。
Nat Biotechnol. 2011 Jul 7;29(8):731-4. doi: 10.1038/nbt.1927.
5
Breaking the code of DNA binding specificity of TAL-type III effectors.破解 TAL 型 III 效应物 DNA 结合特异性的密码。
Science. 2009 Dec 11;326(5959):1509-12. doi: 10.1126/science.1178811.
6
Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA.用于选择性降解突变型人类线粒体DNA的单链准二聚体锌指核酸酶的研发。
Nucleic Acids Res. 2008 Jul;36(12):3926-38. doi: 10.1093/nar/gkn313. Epub 2008 May 29.
7
What causes mitochondrial DNA deletions in human cells?是什么导致人类细胞中的线粒体DNA缺失?
Nat Genet. 2008 Mar;40(3):275-9. doi: 10.1038/ng.f.94.
8
Two ways to make an mtDNA bottleneck.制造线粒体DNA瓶颈的两种方法。
Nat Genet. 2008 Feb;40(2):134-5. doi: 10.1038/ng0208-134.
9
Homoplasmy, heteroplasmy, and mitochondrial dystonia.同质性、异质性与线粒体肌张力障碍。
Neurology. 2007 Aug 28;69(9):911-6. doi: 10.1212/01.wnl.0000267843.10977.4a.
10
Sequence-specific modification of mitochondrial DNA using a chimeric zinc finger methylase.使用嵌合锌指甲基化酶对线粒体DNA进行序列特异性修饰。
Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19689-94. doi: 10.1073/pnas.0609502103. Epub 2006 Dec 14.